DAR-AL-HANDASAH
Ethiopian Airlines Group has announced plans to build Africa’s largest airport in Abusera – a critical element of Ethiopian’s 15-year strategic plan to become one of the most competitive aviation groups in the world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240812311709/en/
Ethiopian Airlines Group CEO Mesfin Tasew and Dar’s Director of Operations in Ethiopia Tariq Al-Qanni sign consultancy contract for new Abusera International Airport. (Photo: AETOSWire)
The airport’s location allows for progressive growth, empowering the airline to meet the International Air Transport Association’s forecasts of more than 200% growth over the next decade – growing beyond Bole International Airport, which offers no possibilities for significant expansion. Abusera’s lower altitude will elevate aircraft take-off performance, while an express rail link to Addis Ababa facilitates connectivity.
In its first phase scheduled for 2029, the airport will have capacity for 60 million passengers annually – almost three times Africa’s current busiest airport – creating thousands of jobs to serve Ethiopian’s expanding customer base and fleet. Ultimately, the airport will serve 110 million passengers annually – four times the capacity of Bole International Airport.
Ethiopian’s CEO Mesfin Tasew stated: “With its exceptional capacity and world-class facilities, this new airport promises to elevate African aviation.”
To deliver this transformational new project, Ethiopian Airlines awarded a consultancy contract to a consortium led by Dar Al-Handasah Consultants (Shair and Partners), with Zaha Hadid Architects (ZHA), Pascall+Watson Architects, Landrum&Brown, and TY Lin.
Dar, TY Lin, and Landrum&Brown belong to Sidara, a global collaborative that ranks 1st in aviation (Engineering News Record 2023). ZHA brings award-winning design capabilities and a global track-record of acclaimed airport projects, while Pascall+Watson Architects has successfully completed over 2,000 aviation projects across 70 airports.
Collectively, these companies will cover technical advisory, engineering, project management, and construction supervision services for 600,000 m2 of passenger facilities, 126,000 m2 of airline support facilities, two Code 4E parallel runways along with associated airfield infrastructure, and other major airport facilities and infrastructure.
About Ethiopian Airlines Group
Ethiopian is one of the fastest-growing airlines globally and the largest in Africa. Building on a highly successful 78-year track record, Ethiopian operates Africa’s most modern fleet to more than 150 destinations across five continents.
https://www.ethiopianairlines.com/et
About Dar
Dar provides design, planning, engineering, and management services for buildings, cities, transportation, and infrastructure projects.
About Zaha Hadid Architects (ZHA)
Founded 45 years ago in London, ZHA offers architecture, design, and planning services worldwide.
Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240812311709/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Curatis: Significantly Increased Sales in Core Business and Projects in Development Pipeline on Track16.9.2024 08:20:00 CEST | Press release
Curatis Holding (SIX:CURN) reports revenues of CHF 2.0m for H1 2024, whereby Curatis AG is only included for 2 months. Curatis AG was able to increase sales in the distribution business by 31% per cent to CHF 4.3m in the entire 6 months of 2024 compared to the first 6 months of 2023. The loss amounted to CHF 3.8m due to non-cash one-off effects and amortisation as well as transaction costs for the acquisition of Curatis AG. Cash flow, including one-time transaction costs for the business combination of over CHF 1 million, was CHF -0.7m. As planned, Curatis also submitted the orphan drug designation application for its lead product candidate C-PBTE-01 to the US Food and Drug Administration (FDA) and expects a response from the FDA in Q4 2024. Business development and finances Product sales in the first half of the year amounted to CHF 1.75m and services revenues to CHF0.23m, whereby Curatis AG, which was acquired on 26 April 2024, is only included in this figure for 2 months. Curatis AG
International ID Day: Thales Stands up for a Legal and Trusted Identity for Everyone16.9.2024 08:00:00 CEST | Press release
On the International Identity Day ‘ID Day’, Thales reaffirms its dedication to supporting global identity initiatives and driving technological advancements that foster inclusion, security, and trust. Around the world, more than 850 million individuals do not have a legal identity, preventing them from claiming their rights and accessing fundamental citizen services e.g. health, education, employment. Thales has been working for more than thirty years to make trustworthy identities a reality for everyone, employing cutting-edge and responsible technology for biometrics and digital ID solutions. On September 16th, Thales celebrates the International Identity Day (ID Day), a symbolic day to highlight the United Nations' Sustainable Development Goal16.9 to provide a legal identity for all. ID Day is dedicated to raising awareness about the importance of legal identity as a fundamental human right and a key enabler of inclusive social and economic development. Thales supports global effort
Incyte’s CDK2 Inhibitor INCB123667 Shows Promising Evidence of Clinical Activity in Patients with Advanced Solid Tumors, Notably Ovarian Cancer14.9.2024 18:45:00 CEST | Press release
New antitumor response data from a range of doses and regimens unveiled today at Incyte investor eventThese results build upon safety and tolerability data presented earlier today during a mini-oral presentation at the European Society of Medical Oncology (ESMO) Congress 2024Findings support the initiation of a pivotal trial in ovarian cancer, expected to begin in 2025; additional plans to evaluate INCB123667 in combination with other treatments are underway Incyte (Nasdaq:INCY) today announced new early clinical data for INCB123667, a highly selective, potential first-in-class CDK2 inhibitor, in patients with advanced solid tumors. The trial results, presented during a mini-oral presentation at the European Society of Medical Oncology (ESMO) with new, updated data shared during the Company’s investor event, highlight the potential of INCB123667 as a differentiated treatment option for cancers with increased Cyclin E1 activity, amplification and/or overexpression in cells predictive of
Incyte’s Retifanlimab (Zynyz®) Extends Progression-Free Survival in Patients with Squamous Cell Anal Carcinoma (SCAC); Data Featured at ESMO 2024 Presidential Symposium14.9.2024 16:30:00 CEST | Press release
- Phase 3 POD1UM-303/InterAACT2 trial met primary endpoint of progression-free survival and demonstrated improvement across secondary endpoints in patients with squamous cell anal carcinoma (SCAC) taking retifanlimab in combination with platinum-based chemotherapy (carboplatin-paclitaxel) - Late-breaking data presented at the European Society for Medical Oncology (ESMO) Congress 2024 support the planned U.S. filing of a supplemental Biologics License Application (sBLA) for retifanlimab in SCAC by year-end 2024 - Incyte to host an in-person analyst and investor event to review key data at ESMO on Saturday, September 14, 2024 from 1:00-2:30 p.m. ET (7:00-8:30 p.m. CEST) Incyte (Nasdaq:INCY) today announced results from the Phase 3 POD1UM-303/InterAACT2 trial of retifanlimab (Zynyz®), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with platinum-based chemotherapy (carboplatin–paclitaxel) for the treatment of adults with inoperable locally recu
Irdeto Partners with Bitmovin to Deliver Industry-Leading Secure Low-Latency Streaming with Unmatched User Experience14.9.2024 10:00:00 CEST | Press release
This joint offering allows operators to benefit from seamless, high-quality streaming, extended device reach, and advanced advertising and security features Irdeto, the global leader in digital video platform experiences and security, and Bitmovin, the industry leader in video software solutions, today announced a strategic partnership to deliver enhanced secure video streaming experiences. This collaboration integrates Bitmovin’s renowned Player and Analytics suite into Irdeto Experience, the award-winning streaming platform trusted by top-tier operators worldwide. Together, they will provide streaming service providers, content owners, and pay-TV operators with cutting-edge solutions that address the critical need for low-latency streaming. The combination of Irdeto’s expertise in security and Bitmovin’s preeminent player offers a powerful and comprehensive solution. This joint offering allows operators to benefit from smooth, high-resolution streaming and advanced advertising and se
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom